SOPHiA GENETICS SASOPH

NasdaqTechnologyServices-Computer Processing & Data Preparation
Price (close)
$8.26
Market cap
$565.7M
P/E
—
Revenue (FY)
$77.3M
Net income
-$79.0M
Dividend yield
—
1-year total return
140.8%
Net margin
-102.2%
Revenue growth
18.6%
Debt / equity
1.01x

What SOPHiA GENETICS SA does.

SOPHiA GENETICS was founded to generate clinically actionable insights from data to improve patient outcomes. Our mission is to provide equal access to knowledge and capabilities by democratizing data-driven medicine.

We observed that across the healthcare ecosystem, a vast amount of digital healthcare data was being generated, fueled by technologies such as NGS, and which held promise to accelerate the understanding of biology and disease. However, this data has been generated primarily using non-standardized methods and by clinicians and researchers across many healthcare institutions. As a result, the data remained siloed and complex and was not fully leveraged for the benefit of patients.

We founded SOPHiA GENETICS to address this issue. We are unlocking data silos, leveraging AI to generate actionable insights from data and helping healthcare professionals work together as a community and deploy their collective expertise for the benefit of patients around the world.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$28.4M$40.5M$47.6M$62.4M$65.2M$77.3M
Net income-$39.3M-$73.7M-$87.4M-$79.0M-$62.5M-$79.0M
Free cash flow-$32.2M-$60.6M-$74.2M-$54.7M-$44.8M-$36.5M

More on SOPH.

Figures from SOPHiA GENETICS SA's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.